Anlon Healthcare (AHCL) — Announcement

📢 Key Event
Board approved Q1 FY2026-27 results and non-cash subsidiary acquisition via share swap

🔄 What Changed
New subsidiary acquisitions (Apiqo Bizotic) and IPO fund utilization status

💡 Investor Takeaway
The acquisition is non-cash and IPO funds are fully deployed, reducing immediate financial risk while expanding operations.

Anlon Healthcare Limited approved its Q1 FY2026-27 unaudited results showing Rs ₹3,103.52 lakhs revenue and Rs [amount context mismatch] lakhs PAT, while announcing a non-cash share swap to acquire 32.52% of Apiqo Organics and 43.33% of Bizotic LifeScience, making them wholly owned subsidiaries. The auditor confirmed no material misstatements in the reviewed financials. The filing also disclosed full utilization of IPO proceeds from August 2025, allocated to capital expenditure, working capital, and general corporate purposes without deviations. This strategic acquisition expands AHCL's manufacturing footprint while maintaining financial discipline through non-dilutive equity consideration.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AHCL ✨ Ask AI About This

About Anlon Healthcare Limited (AHCL)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹709.57 Cr

View full AHCL stock details →

📡 Get AI alerts when AHCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AHCL — Free

💡 Ask AI about this filing

"How will the new subsidiaries impact AHCL's consolidated margins?" "What is the valuation multiple paid for Apiqo and Bizotic?" "When will the IPO fund utilization report be audited?"

Ask AI Free →

📊 More AHCL filings

See all AHCL filings →

🔥 Also filed on 30 July 2026

PARADEEP Paradeep Phosphates Limited Financial Results SYRMA Syrma SGS Technology Limited Offer Document AJANTPHARM Ajanta Pharma Limited Corporate Action GATEWAY Gateway Distriparks Limited Corporate Action AYMSYNTEX AYM Syntex Limited Announcement GILLETTE Gillette India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AHCL files new disclosures

Track AHCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.